Cox; Jason M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cox; Jason M..The latest application filed is for "2-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitors".

Company Profile

8.27.33

Cox; Jason M. - Rancho Santa Fe CA
Cox; Jason M. - Whitehouse Station NJ
Cox; Jason M. - Flemington NJ
Cox; Jason M. - East Windsor NJ
Cox; Jason M - Albuquerque NM
Cox; Jason M. - Albuquerque NM
COX; Jason M. - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors App 20220289710 - Arasappan; Ashok ; et al.	2022-09-15
2-amino-n-heteroaryl-nicotinamides as Na.sub.v1.8 inhibitors Grant 11,377,438 - Arasappan , et al. July 5, 2	2022-07-05
Inhibitors of fibroblast growth factor receptor kinases Grant 11,345,681 - Kaldor , et al. May 31, 2	2022-05-31
Pyrazolopyrimidine Pde9 Inhibitors App 20220017526 - Arasappan; Ashok ; et al.	2022-01-20
Cyclobutyl Pyrazolopyrimidine Pde9 Inhibitors App 20220017525 - Arasappan; Ashok ; et al.	2022-01-20
4-amino Or 4-alkoxy-substituted Aryl Sulfonamide Compounds With Selective Activity In Voltage-gated Sodium Channels App 20220000844 - Bungard; Christopher J. ; et al.	2022-01-06
2-oxoimidazolidine-4-carboxamides As Nav1.8 Inhibitors App 20210403457 - Arasappan; Ashok ; et al.	2021-12-30
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors App 20210387966 - Arasappan; Ashok ; et al.	2021-12-16
Substituted tetrahydroisoquinoline compounds useful as GPR120 agonists Grant 11,161,819 - Adams , et al. November 2, 2	2021-11-02
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors Grant 11,028,092 - Arasappan , et al. June 8, 2	2021-06-08
Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitors Grant 10,934,294 - Arasappan , et al. March 2, 2	2021-03-02
Hydroxy isoxazole compounds useful as GPR120 agonists Grant 10,864,211 - Debenham , et al. December 15, 2	2020-12-15
Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists App 20200347020 - Adams; Gregory L. ; et al.	2020-11-05
Pyrazolopyrimidine Pde9 Inhibitors App 20200140445 - ARASAPPAN; Ashok ; et al.	2020-05-07
2-amino-n-heteroaryl-nicotinamides As Nav1.8 Inhibitors App 20200140411 - Arasappan; Ashok ; et al.	2020-05-07
Composition and Methods for Treating Chronic Kidney Disease App 20190307735 - Cox; Jason M. ; et al.	2019-10-10
Hydroxy Isoxazole Compounds Useful As Gpr120 Agonists App 20190269679 - Debenham; John S. ; et al.	2019-09-05
Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists App 20190161448 - Adams; Gregory L. ; et al.	2019-05-30
Pyrazolopyrimidine Pde9 Inhibitors App 20180354955 - ARASAPPAN; Ashok ; et al.	2018-12-13
Compositions Methods for Treating Chronic Kidney Disease App 20180110762 - COX; Jason M. ; et al.	2018-04-26
Substituted spiropiperidinyl compounds useful as GPR120 agonists Grant 9,708,270 - Chelliah , et al. July 18, 2	2017-07-18
Differential excitation spectroscopy II Grant 9,709,485 - Butler , et al. July 18, 2	2017-07-18
Mineralocorticoid receptor antagonists Grant 9,505,730 - Shen , et al. November 29, 2	2016-11-29
Differential excitation spectroscopy Grant 9,395,311 - Butler , et al. July 19, 2	2016-07-19
Mineralocorticoid receptor antagonists Grant 9,193,717 - Shen , et al. November 24, 2	2015-11-24
Substituted Spiropiperidinyl Compounds Useful As Gpr120 Agonists App 20150274672 - Chelliah; Mariappan ; et al.	2015-10-01
Mineralocorticoid receptor antagonists Grant 9,085,568 - Shen , et al. July 21, 2	2015-07-21
Mineralocorticoid Receptor Antagonists App 20150166490 - Shen; Hong ; et al.	2015-06-18
Differential Excitation Spectroscopy App 20150069258 - Butler; Eugene W. ; et al.	2015-03-12
Mineralocorticoid Receptor Antagonists App 20140275133 - Shen; Hong ; et al.	2014-09-18
Mineralocorticoid Receptor Antagonists App 20140256723 - Shen; Hong ; et al.	2014-09-11
Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes Grant 8,716,482 - Cox , et al. May 6, 2	2014-05-06
Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 8,653,059 - Biftu , et al. February 18, 2	2014-02-18
Aminotetrahydropyrans As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Or Prevention Of Diabetes App 20120149637 - Biftu; Tesfaye ; et al.	2012-06-14
Substituted Aminopiperidines As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Of Diabetes App 20120149683 - Cox; Jason M. ; et al.	2012-06-14
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 8,143,289 - Biftu , et al. March 27, 2	2012-03-27
Heterocyclic Compounds As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Or Prevention Of Diabetes App 20110224195 - Biftu; Tesfaye ; et al.	2011-09-15
Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 8,017,624 - Cox , et al. September 13, 2	2011-09-13
Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes Grant 7,943,615 - Cox , et al. May 17, 2	2011-05-17
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,910,596 - Biftu , et al. March 22, 2	2011-03-22
Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,884,104 - Cox , et al. February 8, 2	2011-02-08
Tricyclic heteroaromatic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,855,206 - Cox , et al. December 21, 2	2010-12-21
Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20100234403 - Biftu; Tesfaye ; et al.	2010-09-16
Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,718,667 - Edmondson , et al. May 18, 2	2010-05-18
Aminotetrahydropyrans As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Or Prevention Of Diabetes App 20100120863 - Biftu; Tesfaye ; et al.	2010-05-13
Tricyclic Heteroaromatic Compounds As Dipeptidyl Peptidase-iv Inhibitors For The Treatment Or Prevention Of Diabetes App 20100056550 - Cox; Jason M. ; et al.	2010-03-04
Fused Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20090258894 - Cox; Jason M. ; et al.	2009-10-15
Fused Aminopiperidines as Dipeptidyl Peptidase-4 Inhibitors for the Treatment or Prevention of Diabetes App 20090233936 - Cox; Jason M. ; et al.	2009-09-17
Aminopiperidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20080076773 - Cox; Jason M. ; et al.	2008-03-27
Fused Aminopiperidine as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20080009510 - Edmondson; Scott D. ; et al.	2008-01-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.